China's clears Pfizer GLP-1 ecnoglutide for weight loss Pfizer has claimed its first regulatory approval for a GLP-1 agonist in obesity, getting a green light in China for ecnoglutide, a once-weekly injectable drug licensed from Hangzhou-based Sciwind Biosciences in February
Peer review Peer review information Nature Reviews Nephrology thanks Ling Zheng, Sarantos Kostidis and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
However, cyclic reaction rate is dramatically increased in the presence of Glutaminyl Cyclase (QC), also known as Glutaminyl-peptide Cyclotransferase (QPCT)
Kopchick is supported by the State of Ohio's Eminent Scholar Program, which includes a gift from Milton and Lawrence Goll, by AMVETS, and by NIH (P01AG031736)
175 showed that a machine learning model called a hyperparameter-optimized light gradient-boosted machine classifier achieved an accuracy of 76.92% in predicting synergy between antimicrobial agents